The number of colorectal cancer (CRC) patients has been increasing rapidly worldwide in recent decades, and the survival rates of CRC patients have increased in the past few years, possibly as a result of progress in diagnostic faculty and improved chemotherapy. The aim of this study was investigating the predictive potential of these available and convenient laboratory dates in stage IV colorectal cancer (CRC) patients. The authors identified the cases of 114 consecutive patients who underwent the surgery at our Hospital between January 2006 and December 2012 by using the multivariate analysis, the Cox proportional-hazard regression model. They divided the patients in 3 groups: 1) metastatic lesion resection group with primary lesion resection (n = 52 in the Met/Prim lesion group), 2) primary lesion resection without metastatic lesion resection (n = 38 in the Primary lesion group) and 3) palliative operation (n = 24 in the Palliative group). Routine laboratory measurements prio
Scientific Research Publishing